Intuitive Surgical, Inc. $ISRG Shares Sold by Strs Ohio

Strs Ohio lessened its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 3.3% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 136,328 shares of the medical equipment provider’s stock after selling 4,661 shares during the period. Strs Ohio’s holdings in Intuitive Surgical were worth $62,846,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Riversedge Advisors LLC increased its holdings in Intuitive Surgical by 1.9% in the 4th quarter. Riversedge Advisors LLC now owns 901 shares of the medical equipment provider’s stock valued at $510,000 after purchasing an additional 17 shares in the last quarter. Fiduciary Financial Group LLC raised its position in Intuitive Surgical by 2.1% in the fourth quarter. Fiduciary Financial Group LLC now owns 920 shares of the medical equipment provider’s stock valued at $521,000 after purchasing an additional 19 shares during the period. Prosperity Consulting Group LLC lifted its stake in shares of Intuitive Surgical by 0.5% during the third quarter. Prosperity Consulting Group LLC now owns 4,033 shares of the medical equipment provider’s stock worth $1,804,000 after purchasing an additional 19 shares in the last quarter. Sunburst Financial Group LLC boosted its position in shares of Intuitive Surgical by 4.3% in the fourth quarter. Sunburst Financial Group LLC now owns 485 shares of the medical equipment provider’s stock worth $275,000 after buying an additional 20 shares during the period. Finally, WoodTrust Financial Corp boosted its position in shares of Intuitive Surgical by 0.5% in the fourth quarter. WoodTrust Financial Corp now owns 4,180 shares of the medical equipment provider’s stock worth $2,367,000 after buying an additional 20 shares during the period. Institutional investors and hedge funds own 83.64% of the company’s stock.

Analysts Set New Price Targets

ISRG has been the topic of several analyst reports. HSBC dropped their target price on Intuitive Surgical from $653.00 to $604.00 and set a “buy” rating on the stock in a report on Wednesday, April 22nd. JPMorgan Chase & Co. decreased their price target on Intuitive Surgical from $625.00 to $550.00 and set an “overweight” rating for the company in a report on Wednesday, April 22nd. Truist Financial lowered their price objective on shares of Intuitive Surgical from $650.00 to $580.00 and set a “buy” rating for the company in a research report on Wednesday, April 15th. Citigroup upgraded shares of Intuitive Surgical from a “neutral” rating to a “buy” rating and set a $590.00 price objective on the stock in a research note on Wednesday, March 11th. Finally, The Goldman Sachs Group set a $558.00 target price on shares of Intuitive Surgical in a research report on Wednesday, May 27th. Nineteen equities research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $573.42.

Trending Headlines about Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Analysts say Intuitive Surgical has a strong earnings-surprise track record and could beat estimates again in its upcoming report. Why Intuitive Surgical (ISRG) Could Beat Earnings Estimates Again
• Positive Sentiment: Investors appear to be buying ahead of the company’s July 16 earnings call, likely betting on continued procedure growth, da Vinci 5 adoption, and another solid update. Intuitive Surgical Gains as Investors Appear to Position for Mid-July Earnings
• Neutral Sentiment: Commentary from an investor letter and market recaps referenced Intuitive Surgical’s recent trading weakness and below-consensus forecast concerns, but these pieces did not add a fresh operational catalyst. Intuitive Surgical (ISRG) Fell on Below-Consensus Forecast
• Negative Sentiment: Some recent coverage notes ongoing pressure from regulatory scrutiny over instrument reuse and competitive concerns in China, which may be weighing on sentiment despite the company’s strong fundamentals. Intuitive Surgical (ISRG) Fell on Below-Consensus Forecast

Intuitive Surgical Stock Performance

NASDAQ:ISRG opened at $426.01 on Friday. The stock has a market cap of $150.88 billion, a price-to-earnings ratio of 51.64, a price-to-earnings-growth ratio of 3.27 and a beta of 1.46. Intuitive Surgical, Inc. has a one year low of $396.68 and a one year high of $603.88. The business’s 50-day simple moving average is $428.43 and its 200 day simple moving average is $480.00.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share for the quarter, beating analysts’ consensus estimates of $2.08 by $0.42. Intuitive Surgical had a return on equity of 15.98% and a net margin of 28.15%.The firm had revenue of $2.77 billion during the quarter, compared to analyst estimates of $2.62 billion. During the same quarter last year, the firm earned $1.81 EPS. Intuitive Surgical’s quarterly revenue was up 23.0% on a year-over-year basis. On average, equities research analysts predict that Intuitive Surgical, Inc. will post 8.57 EPS for the current year.

Insider Activity

In related news, EVP Gary Loeb sold 400 shares of the company’s stock in a transaction on Wednesday, June 10th. The shares were sold at an average price of $424.14, for a total value of $169,656.00. Following the sale, the executive vice president directly owned 5,720 shares of the company’s stock, valued at $2,426,080.80. This represents a 6.54% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Amy L. Ladd sold 500 shares of the company’s stock in a transaction on Tuesday, April 28th. The shares were sold at an average price of $473.46, for a total transaction of $236,730.00. Following the completion of the sale, the director directly owned 239 shares in the company, valued at $113,156.94. This represents a 67.66% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders sold 7,169 shares of company stock worth $3,059,135. 0.60% of the stock is currently owned by insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.